Sana Biotechnology Announces the Acceptance of Four
SEATTLE, March 14, 2023 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on creating and delivering engineered cells as medicines, today announced that four abstracts, including a late-breaking abstract, highlighting preclinical data from both the hypoimmune and fusogen platforms have been accepted for poster presentation at the 2023 American Association for Cancer Research (AACR) Annual Meeting taking place April 14-19, 2023 in Orlando, FL.
Late-breaking poster details:
Title: | Increased potency of CD8-targeted fusosomes enhances CAR gene delivery to resting primary T cells |
Session Title: | Late-Breaking Research: Experimental and Molecular Therapeutics 3 |
Session Date: | Wednesday, April 19, 2023 |
Session Time: | 9:00 a.m. - 12:30 p.m. ET |
Location: | Poster Section 35 |
Abstract Number: | LB311 |
Poster details:
Title: | Modulation of resting T cell status to enhance transduction and CAR T expansion following exposure to CD8-targeted fusosomes |
Session Category: | Experimental and Molecular Therapeutics |
Session Title: | Gene and Vector-based Therapy |
Session Date: | Monday, April 17, 2023 |
Session Time: | 1:30 p.m. - 5:00 p.m. ET |
Location: | Poster Section 16 |
Abstract Number: | 2734 |
Title: | Development of a novel, fully human anti-CD19 chimeric antigen receptor for in vivo delivery via CD8-targeted fusosome |
Session Category: | Experimental and Molecular Therapeutics |
Session Title: | Gene and Vector-based Therapy |
Session Date: | Monday, April 17, 2023 |
Session Time: | 1:30 p.m. - 5:00 p.m. ET |
Location: | Poster Section 16 |
Abstract Number: | 2735 |
Title: | Engineered hypoimmune CAR T cells provide lasting tumor control in immunocompetent allogeneic humanized mice even with re-challenge |
Session Category: | Immunology |
Session Title: | CAR T-cell Therapy 2 |
Session Date: | Tuesday, April 18, 2023 |
Session Time: | 9:00 a.m. - 12:30 p.m. ET |
Location: | Poster Section 23 |
Abstract Number: | 4091 |
Full regular abstracts and late-breaking abstract titles are available for viewing via the AACR Online Itinerary Planner located here: https://www.abstractsonline.com/pp8/#!/10828. Late-breaking abstract text will be posted to the AACR Online Itinerary Planner and Meeting App on Friday, April 14, 2023 at 12:00 p.m. ET.
About Sana Biotechnology
Sana Biotechnology, Inc. is focused on creating and delivering engineered cells as medicines for patients. We share a vision of repairing and controlling genes, replacing missing or damaged cells, and making our therapies broadly available to patients. We are a passionate group of people working together to create an enduring company that changes how the world treats disease. Sana has operations in Seattle, Cambridge, South San Francisco, and Rochester. For more information about Sana Biotechnology, please visit https://sana.com/.
Cautionary Note Regarding Forward-Looking Statements
This press release contains forward-looking statements about Sana Biotechnology, Inc. (the “Company,” “we,” “us,” or “our”) within the meaning of the federal securities laws, including those related to the Company’s vision, progress, and business plans; expectations for the Company’s participation at the 2023 American Association for Cancer Research Annual Meeting; expectations for the Company’s presentations at such meeting, including the content of such presentations; and expectations for the publication of abstracts. All statements other than statements of historical facts contained in this press release, including, among others, statements regarding the Company’s strategy, expectations, cash runway and future financial condition, future operations, and prospects, are forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as “aim,” “anticipate,” “assume,” “believe,” “contemplate,” “continue,” “could,” “design,” “due,” “estimate,” “expect,” “goal,” “intend,” “may,” “objective,” “plan,” “positioned,” “potential,” “predict,” “seek,” “should,” “target,” “will,” “would,” and other similar expressions that are predictions of or indicate future events and future trends, or the negative of these terms or other comparable terminology. The Company has based these forward-looking statements largely on its current expectations, estimates, forecasts and projections about future events and financial trends that it believes may affect its financial condition, results of operations, business strategy and financial needs. In light of the significant uncertainties in these forward-looking statements, you should not rely upon forward-looking statements as predictions of future events. These statements are subject to risks and uncertainties that could cause the actual results to vary materially, including, among others, the risks inherent in drug development such as those associated with the initiation, cost, timing, progress and results of the Company’s current and future research and development programs, preclinical and clinical trials, as well as the economic, market and social disruptions due to the ongoing COVID-19 public health crisis. For a detailed discussion of the risk factors that could affect the Company’s actual results, please refer to the risk factors identified in the Company’s SEC reports, including but not limited to its Quarterly Report on Form 10-Q dated November 2, 2022. Except as required by law, the Company undertakes no obligation to update publicly any forward-looking statements for any reason.
Investor Relations & Media:
Nicole Keith
[email protected]
[email protected]

TIN LIÊN QUAN
Beam Therapeutics to Participate in the 43rd Annual Cowen
CAMBRIDGE, Mass., March 01, 2023 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic...
Lyra Therapeutics Announces Appointment of John Bishop,
WATERTOWN, Mass., Feb. 27, 2023 (GLOBE NEWSWIRE) -- Lyra Therapeutics, Inc. (Nasdaq: LYRA) (the Company or Lyra), a clinical-stage biotechnology company...
Molecular Partners to Present at SVB Leerink Global
ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., Feb. 10, 2023 (GLOBE NEWSWIRE) -- Molecular Partners AG (SIX: MOLN; NASDAQ: MOLN), a clinical-stage...
REE Automotive, Ltd. Announces Date for Fourth Quarter 2022
TEL-AVIV, Israel, March 09, 2023 (GLOBE NEWSWIRE) -- REE Automotive, Ltd. (NASDAQ: REE) (“REE” or the “Company”), an automotive technology company and...
NeuroMetrix, Inc. Announces Date for Fourth Quarter and
WOBURN, Mass., Feb. 16, 2023 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) announced today that it plans to issue its 2022 fourth quarter and year...
Additional Data on Lumos OraGrowtH Trials Presented
Oral Presentation Highlighting Data on 15 Subjects from OraGrowtH212 Trial Supportive of Conclusions from Interim Data Analysis Baseline Characteristics...
05/2023 Green Hydrogen Systems announces changes to its
Company announcement 05/2023 Green Hydrogen Systems announces changes to its Board of Directors Kolding, Denmark, 1 March 2023 – In connection with...
Notice of the Annual General Meeting 2023 of Copenhagen
Notice is hereby given of the Annual General Meeting of Copenhagen Airports A/S to be held on Thursday, 30 March 2023 at 3:00 pm. The notice, including...
THỦ THUẬT HAY
Cách đặt phòng khách sạn với Agoda, chọn phòng giá rẻ
Sử dụng Agoda la cách giúp bạn có được căn phòng giá rẻ mà tốt nhất, hơn thế nữa đặt phòng khách sạn với Agoda bạn còn nhận được rất nhiều ưu đãi chính là từ ứng dụng cũng như các đối tác liên kết với Agoda.
Cách đặt ảnh 360 độ làm ảnh bìa trên Facebook
Khi cập nhật ứng dụng Facebook trên Android và iOS, nguồ dùng sẽ được sử dụng tính năng mới đặt ảnh 360 độ làm ảnh bìa trên Facebook.
Sửa lỗi Automatic Repair Loop trên Windows 10
Lỗi Automatic Repair Loop là một trong những lỗi gây nhiều khó chịu nhất cho người dùng máy tính Windows. Điều đáng nói là tính năng Automatic Repair được tích hợp sẵn trên Windows không bao giờ tự động sửa chữa các
Không thể tập trung làm việc vì mê Facebook? Hãy thử ứng dụng này
Chỉ cần cài đặt tiện ích Kill Newsfeed lên trình duyệt web Chrome, bạn sẽ nhận được một dòng hiển thị to đùng trên NewsFeed Facebook: Đừng để Facebook quyến rũ mình!
9 cách khắc phục lỗi không truy cập được vào Facebook
Người dùng Internet Việt Nam không thể truy cập vào được Facebook. Bạn đã thử nhiều cách, trong đó có thiết lập DNS mới (Google DNS, Open DNS, Norton DNS,…) cho máy tính nhưng không hiệu quả. Chưa biết rõ nguyên nhân
ĐÁNH GIÁ NHANH
Đánh giá Honor Play: Lựa chọn không thể bỏ qua với những tín đồ của Gaming Mobile
Tuy là mẫu điện thoại được chú trọng vào hiệu suất chơi game, nhưng không vì thế mà những phần khác của Honor Play bị bỏ quên, trái lại còn được chăm chút khá tốt. Màn hình và thiết kế là một ví dụ, máy sở hữu màn hình
Trên tay máy nghe nhạc FiiO X3 Mark III: hoàn thiện tốt, hơi lag, chất âm tương xứng với giá 4,8tr
Với mức giá gần 5 triệu đồng, FiiO X3 Mark III mang đến cho chúng ta một chiếc máy nghe nhạc kích thước nhỏ gọn, vừa tay, nhẹ nhàng dễ cầm, chất lượng hoàn thiện máy tốt với thiết kế đơn giản, phần mềm điều khiển duyệt
Hongqi E-HS9 - Xứng danh "Rolls-Royce của Trung Quốc"
Thiết kế “chuẩn” Rolls-Royce, khoang nội thất tràn ngập công nghệ, hệ truyền động điện mạnh mẽ và thân thiện với môi trường, cảm giác lái ổn định,... Tất cả đều được gói gọn trong một chiếc xe được mệnh danh là